Researcher
Thomas Gevaert
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Department of Development and Regeneration (Department)
Member
From1 Jan 2024 → Today - Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → Today - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2018
Projects
1 - 4 of 4
- The role of stromal components in urothelial cancerFrom4 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better stratification of intermediate- and high-risk non-muscle-invasive bladder cancer patientsFrom1 Sep 2016 → 1 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of hydroxymethylation as an epigenetic mark in prostate cancer biologyFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- The role of TET1 in the development and progression of prostate cancerFrom1 Sep 2014 → 31 Dec 2019Funding: BOF - Doctoral projects
Publications
1 - 10 of 57
- Optimizing treatment and follow-up of patients with bladder cancer: risk stratification and biomarkers(2022)
Authors: Tim Muilwijk, Steven Joniau, Maarten Albersen, Thomas Gevaert
- PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives(2021)
Authors: Thomas Gevaert
Pages: 162 - 170 - The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort(2020)
Authors: Tim Muilwijk, Murat Akand, Lisa Moris, Thomas Gevaert, Hendrik Van Poppel, Maarten Albersen, Steven Joniau
Pages: 704 - 714 - Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view(2020)
Authors: Thomas Gevaert
Pages: 539 - 544 - TRPV4 Mediates Acute Bladder Responses to Bacterial Lipopolysaccharides(2020)
Authors: Robbe Naert, Thomas Gevaert, Wouter Everaerts, Thomas Voets, Dirk De Ridder, Karel Talavera Pérez
- Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection(2020)
Authors: Cédric Draulans, Wouter Everaerts, Sofie Isebaert, Thomas Gevaert, Raymond Oyen, Steven Joniau, Annouschka Laenen, Birgit Weynand, Gilles Defraene, Gert De Meerleer, et al.
Pages: 713 - 718 - Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers(2020)
Authors: Thomas Gevaert
Pages: 231 - 243 - Prognostic score predicts overall survival following complete urinary tract extirpation(2020)
Authors: Murat Akand, Tim Muilwijk, Frank Van der Aa, Thomas Gevaert, Lisa Moris, Hendrik Van Poppel, Maarten Albersen, Steven Joniau
Pages: 70 - 79 - Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms(2020)
Authors: Thomas Gevaert
Pages: 1286 - 1292 - PD-L1 assessment in urothelial carcinoma: a practical approach(2019)
Authors: Thomas Gevaert